eMRI’s research is focused on developing new materials and devices for nano-, info- and bio-technologies. Comprised of an interdisciplinary team of 14 faculty from chemistry, engineering, physics and pharmaceutical sciences, the eMRI’s research agenda seeks to characterize and control material processes at the nano-, micro- and mesoscales for a variety of applications: controlling light transmission, revolutionary improvements to fuel cells' performance, computational modeling of processes at the nanoscale, tumor-targeted drug delivery, novel anticancer chemotherapies and mitochondrial gene therapy. eMRI also aims to educate the next generation of scientists and technologists by developing interdisciplinary educational programs at the B.S., M.S., Ph.D. and Certificate levels in nanomaterials science and engineering. eMRI has a vigorous outreach program to industry and the urban community. eMRI faculty have developed partnerships with industrial companies and government laboratories including the Air Force Research Laboratories at Hanscom, Foster-Miller, Sandia National Laboratories, Denora, United Technologies Corp., Peugeot, Mitovec, Genzyme, Protonex, Nissan and Integrated Fuel Cells. Founded in 2002.